Damo: The Axsome Therapeutics (AXSM.US) rating was raised from a wait-and-see shareholding rating to an increase rating, and the target price was adjusted from $90.00 to $115.00.
大摩：上调Axsome Therapeutics(AXSM.US)评级，由持股观望调整至增持评级, 目标价由90.00美元调整至115.00美元。
Damo: The Axsome Therapeutics (AXSM.US) rating was raised from a wait-and-see shareholding rating to an increase rating, and the target price was adjusted from $90.00 to $115.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.